Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of CL2020 in subacute cervical spinal cord injury
jRCT1080224764Phase 2Completed
- Sponsor
- Life Science Institute
- Start
- Jul 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of CL2020 in spinal cord injury (SCI) (2 arms), sponsored by Life Science Institute. Started Jul 2019; status: completed.
02
Drugs
CL2020
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on jRCT1080224764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224764.